Clinical Research Directory
Browse clinical research sites, groups, and studies.
Superb Microvascular Intraocular Tumor Imaging Study (SMITIS)
Sponsor: Centre Hospitalier Universitaire de Nice
Summary
The diagnosis and monitoring of intraocular tumors are based on multimodal imaging in addition to the clinical examination (ultra-widefield retinal imaging, echography, angiography). Nevertheless, it may be difficult in cases of retinal hemorrhage, small tumor size or atypical presentation. The study of microvascular flow (Superb Microvascular Imaging, SMI) of intraocular tumors could improve the confidence of differential diagnosis when evaluating these suspicious lesions, or even determine whether a lesion is benign or malignant by describing the vascularization of the lesion. The investigators propose to study the microvascular flow patterns of intraocular tumors prior to proton therapy.
Official title: Using the Superb Microvascular Imaging Method in the Diagnosis of Intraocular Tumors (SMITIS)
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
22
Start Date
2022-04-27
Completion Date
2026-01-18
Last Updated
2025-12-03
Healthy Volunteers
No
Conditions
Interventions
Doppler technology
The study of tumor vascularization can help in the differential diagnosis and follow-up of tumors, and therefore can impact the management of patients with tumors
Locations (1)
CHU de Nice
Nice, France, France